Exercise

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public OfferingKestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public Offering

KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare…

2 months ago
Brag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment OptionBrag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment Option

Brag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment Option

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (Nasdaq: TBH) ("Brag House" or the "Company") today…

2 months ago
LZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment OptionLZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment Option

LZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment Option

HUZHOU CITY, China, March 11, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings Limited (NASDAQ: LZMH) (“LZ Technology” or the “Company”),…

2 months ago
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common StockIntelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock

February 21, 2025 16:05 ET  | Source: Intelligent Bio Solutions, Inc. NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent…

2 months ago
Microbix Receives $2.4 Million from Exercise of WarrantsMicrobix Receives $2.4 Million from Exercise of Warrants

Microbix Receives $2.4 Million from Exercise of Warrants

MISSISSAUGA, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator,…

3 months ago
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesBeta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

January 31, 2025 17:56 ET  | Source: Beta Bionics, Inc. IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics,…

3 months ago
NETCLASS TECHNOLOGY INC Announces Full Exercise of Over-Allotment OptionNETCLASS TECHNOLOGY INC Announces Full Exercise of Over-Allotment Option

NETCLASS TECHNOLOGY INC Announces Full Exercise of Over-Allotment Option

January 03, 2025 16:05 ET  | Source: NETCLASS TECHNOLOGY INC. SHANGHAI and HONG KONG, Jan. 03, 2025 (GLOBE NEWSWIRE) --…

4 months ago
Red Cat Holdings Announces Warrant Exercise Transaction with $4.875 Million in Gross ProceedsRed Cat Holdings Announces Warrant Exercise Transaction with $4.875 Million in Gross Proceeds

Red Cat Holdings Announces Warrant Exercise Transaction with $4.875 Million in Gross Proceeds

December 30, 2024 11:10 ET  | Source: Red Cat Holdings, Inc. SAN JUAN, Puerto Rico, Dec. 30, 2024 (GLOBE NEWSWIRE)…

4 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago
Show more Posts